Risk Factor | Alive (n = 70) | Deceased (n = 4) | P |
Age (in years) | 29 (11 - 43) | 30 (8 - 64) | 0.09 |
Female gender n (%) | 29 (41.4) | 3 (75) | 0.299 |
Functional stage III-IV n (%) | 20 (28.6) | 4 (100) | 0.022 |
chest pain n (%) | 7 (10) | 1 (25) | 0.21 |
exertional hepatalgia n (%) | 17 (2.4) | 2 (50) | 0.16 |
cough n (%) | 15 (2.1) | 1 (25) | 0.41 |
Hepatomegaly n (%) | 65 (92.8) | 4 (100) | 0.35 |
Hepato jugular reflux n (%) | 64 (91.4) | 4 (100) | 0.35 |
Edema of the lower limbs n (%) | 63 (90) | 4 (100) | 0.33 |
Ascites n (%) | 60 (85.7) | 4 (100) | 0.27 |
Spontaneous turgidity of the jugular veins n (%) | 47 (67.1) | 4 (100) | 0.35 |
Collateral venous circulation n (%) | 43 (61.4) | 4 (100) | 0.07 |
Pleural effusion n (%) | 44 (62.8) | 2 (50) | 0.31 |
Splenomegaly n (%) | 2 (2.9) | 1 (25) | 0.08 |
Fever n (%) | 2 (2.9) | 1 (25) | 0.08 |
Facial puffiness n (%) | 1 (1.4) | 1 (25) | 0.054 |
Alteration of general condition n (%) | 1 (1.4) | 1 (25) | 0.054 |
Jaundice n (%) | 1 (1.4) | 1 (25) | 0.054 |
mean cardiothoracic ratio (mean) | 0.51 ± 0.033 | 0.50 ± 0.012 | 0.119 |
Pericardial calcifications n (%) | 39 (55.7) | 3 (75) | 0.256 |
atrial fibrillation n (%) | 12 (17.1) | 2 (50) | 0.089 |
peripheral micro-voltage n (%) | 28 (40) | 1 (25) | 0.308 |
Pericardial effusion n (%) | 21 (30) | 0 (0) | 0.127 |
The mean ejection fraction (mean) | 0.58 ± 0.07 | 0.54 ± 0.04 | 0.138 |
RVEDP (mean) | 19.6 (8 - 34) | 16.8 (15 - 37) | 0.12 |